OP

Option Care Health IncNASDAQ OPCH Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

5.346

Middle

Exchange

XNAS - Nasdaq

OPCH Stock Analysis

OP

Avoid

Based on Eyestock quantitative analysis, OPCH`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

49/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

17.5 %

Undervalued

Market cap $B

5.346

Dividend yield

Shares outstanding

179.48 B

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company provides a therapy portfolio through its network of approximately 96 full-service pharmacies and 67 stand-alone ambulatory infusion suites. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It contracts with managed care organizations, third-party payers, hospitals, physicians and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. It administers a range of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, women’s health and others. It partners with health systems across the country to provide an effective post-acute care network.

View Section: Eyestock Rating